Changes to Health Technology Assessment (HTA) in Europe offer new opportunities to streamline processes and get innovative ...

Greeks remain 'spectators' to pharmaceutical innovation. New medicines are frequently approved, but never reach patients.

A recent study reveals that the average duration of ADHD medication for children and adolescents is more than three years. However, reliable, controlled data on the safety of marketed ADHD medicines ...

While both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have released guidance on the ...

A recent study by the University of Turku and the University of Helsinki in Finland and the Finnish Social Insurance Institution Kela reveals that the average duration of ADHD medication for children ...

Experts say the European Vulnerability Database, or EUVD, should be a good resource, but only if ENISA manages to maintain it properly.

The EU's General Court annulled on Wednesday a European Commission decision not to disclose text messages Commission ...

Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry ...